Skip to main content
Top
Metadata
Title
Zoledronic acid (ZOMETA): a significant improvement in the treatment of Bone metastases
Author
Zsuzsanna Nagy
Publication date
01-09-2005
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 3/2005
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/BF02893400

Other articles of this Issue 3/2005

Pathology & Oncology Research 3/2005 Go to the issue

Letter

Reply

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine